Evaluating the impact of metformin targets on the risk of osteoarthritis: a mendelian randomization study. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.joca.2022.06.010
PubMed Identifier: 35803489
Publication URI: http://europepmc.org/abstract/MED/35803489
Type: Journal Article/Review
Volume: 30
Parent Publication: Osteoarthritis and cartilage
Issue: 11
ISSN: 1063-4584